Intuitive Surgical Q2 FY2026 Earnings Call Summary

ISRG NASDAQ Healthcare 📅 2026-07-16 ⏱ ~60 sec read 🟢 Bullish

⏱️ 60-Second Brief Intuitive Surgical · Q2 FY2026

Stock Next Day

▼ 14.15%

$402.33 → $345.42

Revenue

$2.89B

EPS

$2.29

AI Sentiment

🟢 Bullish

The company delivered strong financial results, significant …

📌 Bottom Line: Intuitive reported a robust second quarter for 2026, exceeding expectations with significant growth in revenue and earnings per share, driven by strong procedure volumes and increased placements of its da Vinci and Ion s…

🤖 AI-Assisted Summary — Produced using a custom AI pipeline by Abhi, reviewed for accuracy. · ⚠️ Not financial advice. For informational purposes only. Full Disclaimer →

✍️ EarningsBloom Editorial Team · 📅 Last updated: 2026-07-18 · 📎 Source: SEC EDGAR / Company Press Release

📋 TL;DR — What Happened

Intuitive reported a robust second quarter for 2026, exceeding expectations with significant growth in revenue and earnings per share, driven by strong procedure volumes and increased placements of its da Vinci and Ion surgical systems. This performance highlights the company's continued dominance in robotic-assisted surgery and its successful expansion into new clinical applications.

📊 Key Financial Metrics

Revenue $2.89B

EPS (Diluted) $2.29

YoY Revenue Growth 18.53%

Gross Margin 67.8%

Net Income $818.1M

AI Sentiment 🟢 Bullish The company delivered strong financial results, significant procedure growth, and robust system placements, indicating healthy demand and operational execution despite potential headwinds.

✅ What Went Well

✅ Robust procedure growth across both da Vinci (15%) and Ion (36%) platforms, indicating strong utilization of the installed base and expanding clinical adoption in minimally invasive care.

✅ Significant increase in da Vinci system placements, with 468 systems placed compared to 395 in the prior year, highlighting strong demand for the company's core surgical robotics and the successful rollout of the da Vinci 5 system.

✅ Strong financial performance with $2.89 billion in revenue, representing an 18.53% year-over-year growth, and a substantial increase in GAAP net income to $818.1 million, demonstrating effective operational execution and profitability.

⚠️ Concerns & Risks

⚠️ The company explicitly highlighted the potential for a material adverse impact from tariffs, stating that additional tariffs beyond current expectations could significantly affect financial results and the non-GAAP gross profit margin.

⚠️ Reliance on non-GAAP financial measures, which exclude significant recurring expenses like share-based compensation and amortization of intangible assets, could potentially obscure the full cost structure and underlying profitability for some investors.

⚠️ Risks associated with the overall macroeconomic environment, including inflation, interest rates, and geopolitical conflicts in Ukraine and the Middle East, which could impact customer spending, supply chains, and the company's costs.

🔮 CEO / Management Guidance

Intuitive expects worldwide da Vinci procedure growth to be approximately 13.5% to 15.5% for the full year 2026, aiming to be closer to the midpoint of this range. The company projects a non-GAAP gross profit margin between 68.0% and 69.0% of revenue, including an estimated 1.0% impact from tariffs, and anticipates non-GAAP operating expense growth of 11% to 13% for the year.

💬 Key Quote

We are pleased with company performance this quarter, which reflects the strength of our portfolio – from da Vinci and Ion to our growing digital solutions.” — Dave Rosa, Intuitive CEO

🏢 About Intuitive Surgical

Intuitive Surgical (ISRG) is a publicly listed company on the NASDAQ exchange in the Healthcare sector. EarningsBloom tracks its quarterly earnings calls to provide free AI-generated summaries for investors.

ISRG NASDAQ Healthcare All Intuitive Surgical Summaries →

📈 Want to act on this insight?

🇮🇳 Open Zerodha Account 🌱 Start with Groww 📄 Full Transcript on Seeking Alpha 📚 Learn Financial Analysis

📁 More from Intuitive Surgical

View all earnings summaries for Intuitive Surgical →